Increased levels of ALT, AST, AP, and γGT were observed in NASH-non-HCC and NASH-HCC vs controls (see Table S1, Supplementary Digital Content 1, http://links.lww.com/CTG/A215). Here, GPT is linked to metabolic dysfunction-associated steatohepatitis.